Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Financial Performance and Segment Highlights
CAH logo

Cardinal Health's Revenue Dips 4% but Profits Rise 9% Amid Key Acquisitions

CAH10-QFiling Date: 1/30/2025
Cardinal Health Inc
Description

What this story covers

Cardinal Health's Q2 FY2025 10-Q shows 4% revenue decline to $55.3B from OptumRx loss, but 9% operating earnings growth to $549M via cost savings and specialty pharma. Acquisitions like ION ($1.1B) and GI Alliance ($2.8B) drive diversification; liquidity at $3.8B supports strategy despite opioid risks.

Story snapshot

CompanyCardinal Health Inc
TickerCAH
VariantStandard detailed
Duration13:54
Filing type10-Q
PeriodQ2 2025
IndustryHealthcare & Pharmaceuticals
Accession0000721371-25-000013

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in